Intravascular drug release kinetics dictate arterial drug deposition, retention, and distribution

被引:98
作者
Balakrishnan, Brinda [1 ]
Dooley, John F.
Kopia, Gregory
Edelman, Elazer R.
机构
[1] MIT, Div Hlth Sci, Cambridge, MA 02139 USA
[2] Cordis Corp, Warren, NJ 07059 USA
[3] Brigham & Womens Hosp, Harvard Med Sch, Dept Med, Div Cardiovasc, Boston, MA 02115 USA
关键词
stents; drug delivery; release kinetics; arterial drug deposition; restenosis;
D O I
10.1016/j.jconrel.2007.06.025
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Millions of patients worldwide have received drug-eluting stents to reduce their risk for in-stent restenosis. The efficacy and toxicity of these local therapeutics depend upon arterial drug deposition, distribution, and retention. To examine how administered dose and drug release kinetics control arterial drug uptake, a model was created using principles of computational fluid dynarnics and transient drug diffusion-convection. The modeling predictions for drug elution were validated using empiric data from stented porcine coronary arteries. Inefficient, minimal arterial drug deposition was predicted when a bolus of drug was released and depleted within seconds. Month-long stent-based drug release efficiently delivered nearly continuous drug levels, but the slow rate of drug presentation limited arterial drug uptake. Uptake was only maximized when the rates of drug release and absorption matched, which occurred for hour-long drug release. Of the two possible means for increasing the amount of drug on the stent, modulation of drug concentration potently impacts the magnitude of arterial drug deposition, while changes in coating drug mass affect duration of release. We demonstrate the importance of drug release kinetics and administered drug dose in governing arterial drug uptake and suggest novel drug delivery strategies for controlling spatio-temporal arterial drug distribution. (C) 2007 Elsevier B.V. All rights reserved.
引用
收藏
页码:100 / 108
页数:9
相关论文
共 37 条
[1]   Mechanisms of controlled drug release from drug-eluting stents [J].
Acharya, Ghanashyam ;
Park, Kinam .
ADVANCED DRUG DELIVERY REVIEWS, 2006, 58 (03) :387-401
[2]   In vitro study of release mechanisms of paclitaxel and rapamycin from drug-incorporated biodegradable stent matrices [J].
Alexis, F ;
Venkatraman, SS ;
Rath, SK ;
Boey, F .
JOURNAL OF CONTROLLED RELEASE, 2004, 98 (01) :67-74
[3]   THE BLOOD RHEOLOGY OF MAN AND VARIOUS ANIMAL SPECIES [J].
AMIN, TM ;
SIRS, JA .
QUARTERLY JOURNAL OF EXPERIMENTAL PHYSIOLOGY AND COGNATE MEDICAL SCIENCES, 1985, 70 (01) :37-49
[4]  
ANDERSON J, 1995, COMPUTATIONAL FLUID, P216
[5]  
Axel DI, 1997, CIRCULATION, V96, P636
[6]   Strut position, blood flow, and drug deposition - Implications for single and overlapping drug-eluting stents [J].
Balakrishnan, B ;
Tzafriri, AR ;
Seifert, P ;
Groothuis, A ;
Rogers, C ;
Edelman, ER .
CIRCULATION, 2005, 111 (22) :2958-2965
[7]  
Berne RM., 1998, Physiology
[8]   A novel drug-eluting stent spray-coated with multi-layers of collagen and sirolimus [J].
Chen, MC ;
Liang, HF ;
Chiu, YL ;
Chang, Y ;
Wei, HJ ;
Sung, HW .
JOURNAL OF CONTROLLED RELEASE, 2005, 108 (01) :178-189
[9]  
CHO YI, 1991, BIORHEOLOGY, V28, P241
[10]  
Commandeur Suzan, 2006, J Interv Cardiol, V19, P500, DOI 10.1111/j.1540-8183.2006.00198.x